Envista Holdings Corporation

NVST Healthcare Medical Instruments & Supplies

Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024. In the quarter to June 2026, revenue grew 7.10%, EPS grew 106.3%, free cash flow grew 37.6% and total debt was flat, each against the same quarter a year earlier.

22.90 0.60 −2.55%
Market cap
$3.8B
P/E
38.8×
Fwd P/E
24.4×
Dividend yield
—
F-score
7/9
Altman Z
1.59
Beneish M
−2.50
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — — 4 8 4 3 3 7
P/E ratio
5.52 5.52 5.52 18.44 168.65 21.25 22.79 0.00 0.00 77.54
Altman Z-Score
— — — 1.50 1.33 2.48 2.12 1.70 0.73 1.59
P/S ratio
0.00 0.00 0.00 1.77 2.79 2.90 2.15 1.57 1.32 1.34
P/FCF ratio
8.96 8.96 8.96 12.56 22.29 22.81 50.15 17.99 10.97 15.80
Altman Z″-Score (non-manufacturers)
— — — 2.04 1.25 2.86 2.73 3.10 0.79 2.63
P/Operating CF
29.37 29.37 29.37 21.59 27.84 53.41 50.15 39.43 25.09 33.77
Beneish M-Score
— — — (3.35) (3.03) (2.40) (2.24) (2.74) (3.98) (2.50)
P/B ratio
0.74 0.74 0.74 1.14 1.45 1.79 1.32 0.96 1.13 1.17
Price to Tangible BV
0.74 0.74 0.74 0.00 0.00 0.00 0.00 0.00 144.42 30.17
EV/Sales
0.00 0.00 0.00 2.25 3.26 2.99 2.45 1.79 1.45 1.47
EV/EBITDA
0.00 0.00 0.00 12.76 28.59 15.59 12.99 23.13 0.00 10.78
EV/Operating CF
6.97 6.97 6.97 12.96 22.15 20.76 34.52 16.67 10.84 14.51
EV/FCF
8.96 8.96 8.96 16.03 26.04 23.57 57.17 20.55 12.04 17.32
Quick Ratio
— 0.74 0.72 0.92 0.71 1.16 0.81 1.73 1.63 1.93
Current Ratio
— 1.27 1.23 1.41 0.94 1.52 1.15 2.23 2.04 2.38
Net Debt/EBITDA
0.00 0.00 0.00 2.76 4.12 0.50 1.59 2.89 (0.37) 0.64
Debt/Assets
— 0.00% 0.00% 21.51% 26.10% 20.01% 20.96% 22.91% 26.06% 25.50%
Debt/Equity
— 0.00 0.00 0.37 0.48 0.32 0.33 0.36 0.48 0.47
Asset Turnover
0.00 0.48 0.97 0.38 0.30 0.37 0.39 0.39 0.42 0.49
Operating CF/Net income
1.53 1.19 1.73 1.83 8.53 1.06 0.75 (2.75) (0.30) 5.87
Capex/Depreciation
0.00 (0.40) (0.56) (0.45) (0.24) (0.25) (0.44) (0.31) (0.21) (0.29)
Interest Coverage
— — — 67.34 0.70 5.66 8.31 0.50 (22.37) 5.90
ROE
0.00% 6.14% 4.70% 5.20% 0.92% 8.75% 5.88% (2.39%) (31.47%) 1.56%
ROA
0.00% 5.09% 7.90% 3.63% 0.51% 5.06% 3.69% (1.52%) (18.71%) 0.85%
ROIC
— 0.00% 3.86% 3.16% 0.59% 4.45% 4.01% 0.41% (19.90%) 4.04%
Return on Tangible Assets
0.00% 75.65% 56.63% 37.32% 18.45% 38.19% 50.49% (7.87%) (94.27%) 3.20%
Average Days of Receivables
0.00 60.12 59.00 70.87 57.08 48.29 55.91 57.95 52.77 57.66
Research and Development Expense of Revenue
5.13% 6.13% 6.05% 5.83% 4.49% 4.01% 3.90% 3.65% 3.95% 4.19%
Selling, General and Administrative Expense of Revenue
37.09% 37.79% 39.78% 42.91% 47.93% 40.65% 41.08% 41.18% 46.12% 42.53%
Intangible Assets out of Total Assets
— 0.00 0.81 0.75 0.63 0.64 0.70 0.64 0.54 0.53
Share Based Compensation of Revenue
0.00% 0.44% 0.47% 0.81% 1.17% 1.12% 1.19% 1.20% 1.41% 1.38%
Graham Net Nets
0.22 0.22 0.22 (0.40) (0.29) (0.09) (0.17) (0.17) (0.19) (0.15)
Graham Number
0.00 0.00 0.00 30.67 10.24 34.65 29.42 0.00 0.00 10.79
Earnings Yield
18.10% 18.10% 18.10% 5.42% 0.59% 4.70% 4.39% (2.28%) (33.64%) 1.29%
Free Cash Flow Yield
11.16% 11.16% 11.16% 7.96% 4.49% 4.38% 1.99% 5.56% 9.12% 6.33%
Revenue per Share
17.52 21.98 22.24 16.78 12.09 15.56 15.77 15.38 14.58 16.19
Operating CF per Share
2.62 2.81 3.13 2.92 1.78 2.24 1.12 1.65 1.95 1.64
Capex per Share
0.00 (0.38) (0.56) (0.56) (0.27) (0.27) (0.44) (0.31) (0.20) (0.27)
Free Cash Flow per Share
2.62 2.43 2.56 2.36 1.51 1.98 0.68 1.34 1.76 1.37
Cash per Share
0.00 0.00 0.00 1.55 5.57 6.66 3.73 5.63 6.21 7.21
Shareholders Equity per Share
0.00 0.00 37.74 26.01 23.31 25.17 25.83 25.01 17.04 18.49
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.00 0.00 37.74 26.01 23.31 25.17 25.83 25.01 17.04 18.49
Free Cash Flow
417.00 310.30 327.90 321.30 241.50 318.50 110.30 223.60 302.80 230.90
Working Capital
— 167.00 145.80 292.70 (94.10) 627.60 187.90 962.90 909.60 1,174.00
Capital Expenditures
(49.10) (48.80) (72.20) (76.20) (42.40) (43.10) (72.40) (52.10) (33.70) (44.80)
Net Current Asset Value
— 795.00 (228.40) (1,613.60) (1,564.40) (680.40) (955.50) (687.50) (627.40) (546.10)
EV/EBIT
0.00 0.00 0.00 21.85 144.57 24.51 19.76 145.89 0.00 18.51
Capex to Sales
0.00 0.02 0.03 0.03 0.02 0.02 0.03 0.02 0.01 0.02
Price to Operating Income
0.00 0.00 0.00 17.13 123.75 23.72 17.33 127.69 0.00 16.88
Other line items
Depreciation/Fixed assets
0.00 0.53 0.50 0.58 0.64 0.66 0.57 0.54 0.58 0.52
Cash ROIC
0.00% 0.00% 6.79% 6.33% 3.77% 4.94% 1.78% 3.37% 5.61% 4.00%
Accounts Receivable Turnover
0.00 6.09 6.16 5.06 5.18 7.92 7.08 6.41 6.52 6.86
Accounts Payable Turnover
9.88 10.03 5.66 4.40 4.26 5.58 5.29 5.52 6.43 6.73
Inventory Turnover
8.78 8.91 4.48 3.36 3.54 4.51 3.88 4.02 4.55 4.66
Average Days of Payables
4.76 68.11 63.85 81.15 84.54 62.65 76.15 58.19 56.01 56.73
Days of Inventory on Hand
(2.77) 84.68 81.86 108.42 90.18 88.96 100.33 83.89 77.30 85.30
Average Receivables
— 461.50 461.40 451.70 372.65 316.80 362.70 400.50 385.25 396.30
Average Payables
118.65 118.65 219.70 212.70 205.25 194.15 207.05 203.90 177.05 183.10
Average Inventory
133.55 133.55 277.35 278.30 246.95 239.90 282.30 279.80 249.90 264.55
Average Assets
— 5,917.50 2,920.80 5,999.95 6,517.15 6,725.10 6,580.60 6,596.05 5,977.80 5,514.75
Average Common Equity
— 4,907.00 4,908.70 4,184.60 3,631.90 3,889.50 4,132.45 4,190.40 3,554.35 3,020.55

Fold the line items

Columns are period end dates